The Association of the British Pharmaceutical Industry has named Virginia (Ginny) Acha as Executive Director – Research Medical and Innovation (RM&I). Dr Acha will take up the position at the beginning of March and report directly to ABPI Chief Executive Stephen Whitehead.
Dr Acha currently works for Amgen as Director, Global Regulatory and R&D Policy – Europe, Middle East and Africa. She holds the chair for the Pharmacovigilance working group in the IFPMA Bio therapeutics Committee, and is the Vice-Chair for the European Biopharmaceutical Enterprises (EBE) Biosimilars Task Force and the lead for the EFPIA Regulatory Network supporting Turkey.
